Effects of trapidil after crush injury in peripheral nerve.
In this study, we evaluated the effects of trapidil on crush injury by monitoring nitric oxide, malondialdehyde and transforming growth factor-Beta2 levels and by transmission electron microscopy in the rat sciatic nerve. The sciatic nerve was compressed for 20 sec by using a jewelers forceps. Trapidil treatment groups were administrated a single dose of trapidil (8 mg/kg) intraperitoneally just after the injury. The crush and crush + trapidil treatment groups were evaluated on the 2nd, 7th, 15th, 30th and 45th days of the post-crush period. On the 7th and 15th days, damage in thin and thick myelinated axons, endoneural edema and mitochondrial swelling were less severe in the trapidil group histopathologically. These findings supported the idea that trapidil prevented cell damage and edema at the injury site. Day/group interaction with regard to serum nitric oxide, malondialdehyde and transforming growth factor-Beta2 levels did not show significant changes.
Kurtoglu
Zeliha
Z
Department of Anatomy, Mersin University, Faculty of Medicine, Turkey. zkurtoglu@mersin.edu.tr
Ozturk
Ahmet Hakan
AH
Bagdatoglu
Celal
C
Polat
Gurbuz
G
Aktekin
Mustafa
M
Uzmansel
Deniz
D
Camdeviren
Handan
H
Bagdatoglu
Ozlen
O
Sargon
Mustafa
M
D000818:Animals; D004487:Edema / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D005260:Female; D007274:Injections, Intraperitoneal; D008315:Malondialdehyde / Q000378:metabolism; D046529:Microscopy, Electron, Transmission; D009186:Myelin Sheath / Q000473:pathology / Q000648:ultrastructure; D009409:Nerve Crush; D009566:Nitrates / Q000378:metabolism; D009573:Nitrites / Q000378:metabolism; D051381:Rats; D011919:Rats, Inbred Strains; D012584:Sciatic Nerve / Q000293:injuries* / Q000378:metabolism / Q000473:pathology; D020426:Sciatic Neuropathy / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D016212:Transforming Growth Factor beta / Q000378:metabolism; D053781:Transforming Growth Factor beta2; D014192:Trapidil / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology*
D009566:Nitrates; D009573:Nitrites; D016212:Transforming Growth Factor beta; D053781:Transforming Growth Factor beta2; D014665:Vasodilator Agents; D008315:Malondialdehyde; D014192:Trapidil